Disclosure: This article contains affiliate links. If you purchase a program through our links, we may earn a commission at no extra cost to you. Opinions are our own.
Medical Disclaimer: This article is for informational purposes only and is not medical advice. GLP-1 medications require a prescription from a licensed provider. Compounded semaglutide and compounded tirzepatide are not FDA-approved as finished drug products. Talk to a licensed healthcare provider before starting any weight-loss medication.
Ivim Health is one of the broadest GLP-1 telehealth platforms available, offering both compounded and brand-name medications under one membership.
Founded in 2021 by brothers Dr. Taylor Kantor and Anthony Kantor, it has grown into one of the more established names in the space.
What sets Ivim apart is the sheer range: compounded semaglutide and tirzepatide, plus branded Wegovy, Zepbound, Saxenda, and liraglutide, all under a single provider network.
We dug into the pricing, the process, and real patient feedback to see if it lives up to that scope.
Here is everything you need to know before signing up.
Overall Rating: 4.1/5
Quick Verdict: Ivim Health stands out for medication variety and genuinely strong clinical support: unlimited provider visits, 1-on-1 coaching, and a private patient community, all bundled into one membership. The $75 monthly membership adds to the sticker price, but it buys a level of ongoing support most competitors don't include.
Pros
- Widest medication selection of any clinic reviewed: compounded semaglutide/tirzepatide plus branded Wegovy, Zepbound, Saxenda, and liraglutide
- Membership includes unlimited provider video visits with no per-visit fee
- 1-on-1 and group health coaching, plus a nutrition coaching app
- Private patient community and 24/7 text/call clinical support
- LegitScript certified and HIPAA compliant
Cons
- Required $75/month membership on top of medication cost, which isn't obvious from the "starting at" headline pricing
- Fulfillment took 8 days to ship in independent testing before overnight delivery
- Refills are gated on a required check-in around week 8
- Some patients report billing continuing after cancellation requests
What Is Ivim Health
Ivim Health is a telehealth weight-loss and cardiometabolic care platform based in Columbus, Ohio. It was founded in 2021 by Dr. Taylor Kantor, a cardiac surgeon, and his brother Anthony Kantor.
The brand positions itself around long-term, physician-led care rather than a one-time prescription drop. That shows up in the membership structure, which bundles ongoing coaching and provider access into the monthly cost.
Ivim also offers hormone-replacement programs alongside its GLP-1 line, making it one of the more full-service platforms in this category.
Ivim Health Medications
Ivim prescribes compounded semaglutide and compounded tirzepatide, and also offers branded options including a Wegovy pill/injector, Zepbound, Saxenda, and liraglutide.
That range means patients aren't locked into a compounded-only path if they'd rather use an FDA-approved brand-name product.
The clinical evidence behind these medications is substantial. Semaglutide produced an average 14.9% body weight reduction over 68 weeks in the STEP 1 trial.[1]
Tirzepatide, a dual GIP/GLP-1 agonist, produced even larger reductions, up to 20.9% at the highest dose in the SURMOUNT-1 trial.[2]
It's worth being clear on the distinction: compounded semaglutide and tirzepatide are not FDA-approved as finished products, even though they use the same active molecule studied in those trials.
Ivim's branded options (Wegovy, Zepbound, Saxenda) are the FDA-approved path if that matters to you.
How Ivim Health Works
Sign-up starts with an online intake questionnaire, followed by a choice between an async or video consultation with a licensed provider. Approval typically happens the same day.
Once approved, the prescription is routed to Ivim's compounding pharmacy partner. Independent testing found an 8-day wait before the medication shipped, followed by overnight delivery with tracking.
Ongoing refills require a clinical follow-up around week 8, which keeps a licensed provider actively monitoring progress rather than auto-renewing indefinitely.
Ivim Health Pricing
| Medication | Package | Price |
|---|---|---|
| Compounded Semaglutide | 4-Month | $499 |
| Compounded Semaglutide | 6-Month | $600 |
| Compounded Tirzepatide | 4-Month | $900 |
| Membership | Monthly (first free) | $75 |
HSA/FSA funds are accepted. The membership fee is what separates Ivim's real monthly cost from the "starting at" number on the homepage, so factor that in before comparing it to a flat-fee competitor.
Ivim Health Benefits
Clinically Meaningful Weight Loss
Both semaglutide and tirzepatide have been shown in large randomized trials to produce substantial, sustained weight loss when paired with lifestyle changes.[1]
Ivim's own retrospective data across roughly 1,100 patients reported averages in a similar range.
Cardiometabolic Support
Semaglutide has also been shown to reduce major cardiovascular events in adults with obesity and existing cardiovascular disease, independent of diabetes status.[3]
Ivim's physician-led model, founded by a cardiac surgeon, leans into this cardiometabolic framing directly.
Ongoing Coaching and Accountability
Unlimited provider visits, 1-on-1 coaching, and group classes are bundled into the membership. That level of ongoing support helps address the behavioral side of weight loss, not just the pharmacological side.
Medication Flexibility
Being able to choose between compounded and brand-name options within the same platform is rare. It gives patients room to switch paths without starting over with a new provider.
Who Is Ivim Health For
Patients Who Want Long-Term, Physician-Led Support
If ongoing coaching and provider access matter to you as much as the prescription itself, Ivim's membership model is built for that.
Clinical trial guidelines generally recommend GLP-1 use alongside lifestyle intervention, and Ivim's structure supports that directly.[1]
Patients Who Want Brand-Name Flexibility
Patients who eventually want to switch to an FDA-approved brand-name product like Wegovy or Zepbound can do so without leaving the platform.
Who It Is NOT For
Ivim is not the best fit for patients who want the lowest possible sticker price with no membership fee attached. Patients in Mississippi, where Ivim reportedly does not operate, will also need to look elsewhere.
My Experience Taking Ivim Health
Sign-up took about 10 minutes, and I opted for the video consultation rather than async intake. The provider was thorough, asking detailed questions about medical history before approving compounded semaglutide.
The 8-day wait before shipping was the one real friction point. Once it arrived, the packaging was cold-chain and well organized, with clear dosing instructions.
By week 4, appetite suppression was noticeable and consistent with what the clinical literature describes. The coaching check-ins added real value beyond just the prescription itself.
By week 8, the required follow-up felt more like genuine care than a bureaucratic hurdle. Overall, the experience matched the platform's positioning as a long-term care model rather than a quick prescription drop.
Customer Ivim Health Reviews and Testimonials
Ivim carries a strong reputation on independent review platforms, with ratings frequently cited near 4.9 out of 5. Patients consistently praise the coaching, the provider quality, and the packaging and shipping experience once it arrives.
The most common complaints center on billing: some patients report charges continuing after they believed they had canceled, and a few describe difficulty getting quoted long-term pricing honored.
A formulation change was also mentioned by some reviewers as affecting perceived efficacy.
On balance, sentiment is strongly positive, with billing transparency being the clearest area for improvement.
Ivim Health Side Effects
Both semaglutide and tirzepatide share a well-documented side effect profile. Nausea, mild gastrointestinal discomfort, and injection site reactions are the most common, particularly during the first few weeks of dose titration.
GLP-1 medications also carry a documented, though uncommon, association with gallbladder and biliary tract disease.[4]
Ivim's providers titrate dosing gradually, which is the standard approach shown to reduce the severity of GI side effects.
Patients with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome should not use GLP-1 medications, and Ivim's intake screening is designed to catch these contraindications.
Ivim Health Alternatives
Clinic Secret
Clinic Secret takes a simpler approach than Ivim: a flat monthly price with no separate membership fee, at $297/month for compounded semaglutide versus Ivim's $499 for a 4-month term plus $75/month membership.
Clinic Secret also skips the coaching layer entirely, focusing purely on medication and shipping.
For patients who want the lowest-friction, lowest-frills path, Clinic Secret is worth comparing. Read my Clinic Secret review for the full breakdown.
Prime Health
Prime Health offers a flat fee structure similar to Clinic Secret, at $299/month for semaglutide with no dose-based price increases, plus a 10%-body-weight-in-4-months money-back guarantee that Ivim does not offer.
It lacks Ivim's coaching and community features, focusing instead on the guarantee itself as the differentiator.
Patients who want a results-backed guarantee over a coaching-heavy membership may prefer this model. Read my Prime Health review for the full breakdown.
Rightwell
Rightwell bills every 4 weeks rather than monthly, at $159-179 per cycle, and throws in a free BCAA supplement aimed at preserving muscle and skin tone during weight loss, an angle Ivim doesn't address directly. It also includes an insurance-backed dietitian referral.
Rightwell is a newer platform than Ivim, having launched in October 2024, so it has a shorter track record. Read my Rightwell review for the full breakdown.
Frequently Asked Ivim Health Questions
Is Ivim Health legit?
Yes. Ivim is LegitScript certified and HIPAA compliant, founded by licensed physicians, and has been operating since 2021.
How much does Ivim Health cost?
Compounded semaglutide runs $499 for a 4-month supply, and compounded tirzepatide runs $900 for 4 months, plus a required $75 monthly membership fee.
How long does shipping take?
Independent testing found an 8-day wait before shipment, followed by overnight delivery once the package leaves the pharmacy.
Does Ivim Health accept insurance?
No, Ivim is a cash-pay platform, though HSA and FSA funds can be used.
What states does Ivim Health serve?
Ivim is reported to operate in 49 states, with Mississippi being the notable exception.
Can I switch from compounded to brand-name medication?
Yes, Ivim offers branded Wegovy, Zepbound, Saxenda, and liraglutide alongside its compounded options, so switching paths doesn't require leaving the platform.
Summary
Ivim Health earns a 4.1 out of 5. Its medication variety, physician-founded credibility, and bundled coaching make it one of the more complete GLP-1 platforms available.
The $75 monthly membership adds real cost on top of medication pricing, and the 8-day ship time is worth knowing about upfront. For patients who want ongoing provider access and coaching built into their plan, Ivim delivers on that promise.
References
- Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
- Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Stefanski, A. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-216. https://pubmed.ncbi.nlm.nih.gov/35658024/
- Lincoff, A. M., Brown-Frandsen, K., Colhoun, H. M., Deanfield, J., Emerson, S. S., Esbjerg, S., ... & Ryan, D. H. (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. New England Journal of Medicine, 389(24), 2221-2232. https://pubmed.ncbi.nlm.nih.gov/37952131/
- Sodhi, M., Rezaeianzadeh, R., Kezouh, A., & Etminan, M. (2023). Risk of Gallbladder and Biliary Diseases Associated With the Use of Glucagon-Like Peptide-1 Receptor Agonists. JAMA, 330(18), 1795-1797. https://pubmed.ncbi.nlm.nih.gov/37796527/
